Skip to main content
. 2022 Sep 16;17(9):e0274703. doi: 10.1371/journal.pone.0274703

Table 1. Characteristics of individuals diagnosed with invasive cancer between 2005 and 2016 cancer by incarceration status at cancer diagnosis.

Characteristic Incarcerated (N = 239) 12-months post release (N = 479) Never incarcerated (N = 215,822) p-value
No. (%) No. (%) No. (%)
Age at diagnosis (years) <0.001
    18–30 22 (9.2) 25 (5.2) 3489 (1.6)
    >30–50 102 (42.7) 197 (41.1) 28389 (13.2)
    >50–70 104 (43.5) 241 (50.3) 99237 (46.0)
    >70 11 4.6) 16 (3.3) 84707 (39.2)
Race and Ethnicity*       <0.001
    Non-Hispanic White 112 (46.9) 236 (49.3) 181358 (84.0)
    Non-Hispanic Black 83 34.7) 156 (32.6) 14913 (6.9)
    Hispanic >39 (>16.3) >82 (>17.1) 13677 (6.3)
    Other <5 (<2.1) <5* (<1.0) 5874 (2.7)
Sex       <0.001
    Male 216 (90.4) 412 (86.0) 103317 (47.9)
    Female 23 (9.6) 67 (14.0) 112505 (52.1)
Cancer Type (categories)*       <0.001
    Breast 6 (2.5) 25 (5.2) 34622 (16.0)
    Gastrointestinal 61 (25.5) 157 (32.8) 38376 (17.8)
    Thoracic 38 (15.9) 64 (13.4) 28247 (13.1)
    Male Reproductive 29 (12.1) 68 (14.2) 31120 (14.4)
    Leukemia & Lymphoma 37 (15.5) 45 (9.4) 19743 (9.1)
    Urinary (non-reproductive) 11 (4.6) 37 (7.7) 12683 (5.9)
    Skin 5 (2.1) 6 (1.3) 10268 (4.8)
    Head and Neck 28 (11.7) 40 (8.4) 14856 (6.9)
    Female Reproductive 5 (2.1) 6 (1.3) 13299 (6.2)
    Central Nervous System (CNS) <5 (<2.1) 8 (1.7) 3123 (1.4)
    Sarcoma 8 (3.3) 12 (2.5) 1823 (0.8)
    Other >6 (>2.5) 11 (2.3) 7662 (3.6)
Cancer stage       <0.001
    Localized 72 (30.1) 185 (38.6) 103561 (48.0)
    Regional 56 (23.4) 130 (27.1) 45715 (21.2)
    Distant 102 (42.7) 136 (28.4) 53971 (25.0)
    Unknown/unstaged 9 (3.8) 28 (5.8) 12575 (5.8)
Screenable cancer** <0.001
    Screenable 51 (21.3) 120 (25.1) 84551 (39.2)
    Non-screenable 188 (78.7) 359 (74.9) 131271 (60.8)

Note: No = Number

* cell sizes containing fewer than 5 individuals are suppressed due to privacy concerns

**screenable cancer types include breast, colorectal, cervical, and prostate.